Get In Touch!

Contact us today to see how we can help you maximize your benefit and program investments for a better future in uncertain times.

Request a Demo

Our Heart Is In Public Health

We help public health programs maximize limited resources and improve outcomes by connecting people to the services and medications they need... for a better life.

Press Releases

Ramsell Partners With Drug Assistant to Help Clinics and Hospitals Increase Patient Access to Medications

OAKLAND, Calif., February 21, 2012 – Ramsell, a pharmacy benefit and 340B solutions provider, today announced a partnership with Drug Assistant, a leading provider of Patient Assistance Program (PAP) management software, to help clinics and hospitals increase access to medications for patients who are unable to pay.

"As a 340B program manager, we see the increased need for PAP medications," said Eric Flowers, CEO of Ramsell. "Our partnership with Drug Assistant will help our clients provide PAP medications to eligible patients at reduced or no cost, and fulfill our mission of serving the underserved and improving patient outcomes. Our common goal is to connect patients to the medications they need."

Drug Assistant's web-based software empowers healthcare providers with a cost-effective solution to automate the PAP application process and to ensure access to medications for their patients. PAP programs assist qualified patients that are uninsured, underinsured, and meet eligibility guidelines established by the pharmaceutical manufacturer to receive prescriptions for free or at a discounted rate. The Drug Assistant application reduces the financial burden by healthcare providers that are currently funding patient medications.

Ramsell helps hospitals and clinics increase access, improve outcomes and reduce costs with comprehensive solutions that maximize the value of the 340B Drug Pricing Program, which provides significant savings on medications. Ramsell applies nearly 20 years of in-depth expertise to help clinics and hospitals implement and manage this complex, regulated program. The savings generated from these programs allow healthcare facilities to increase patient services, serve more patients and improve patient outcomes.

"This is an ideal partnership, as we are both focused on increasing medication access, and we applaud Ramsell's passion to serve the underserved," said Brett Dennis, VP Business Development at Drug Assistant. "We admire their work and are excited that Drug Assistant can be a part of making a difference to those in the community that need it the most."

About Ramsell Holding Corporation
Ramsell is a subsidiary of Ramsell Corporation, a company that has been creating positive outcomes for the health and safety of underserved populations since 1964. We help organizations maximize limited resources through cost-effective coordination of care and services for complex populations managed by public health programs, education and corrections. Ramsell offers highly-configurable, web-based technology solutions, services and expertise to assist our clients in connecting people to the services they need. Ramsell provides solutions for pharmacy benefit management, 340B program management, medication therapy management and correctional applications for discharge planning and community supervision. For more information, go to:

About Drug Assistant
Drug Assistant manages all manufacturers' giveback programs including Inpatient Drug Restocking, Infusion Programs and Patient Assistance. The software helps determine eligibility, compiles and updates a database of available PAP drugs, and assists with ongoing renewals. Drug Assistant's web-based system interfaces with existing accounting, admission and pharmacy software to better automate the process of patient assistance. Providers utilize the program to matches patients with more than 2,500 medications available in Patient Assistant Programs (PAP) offered by pharmaceutical manufacturers at reduced or no cost. Drug Assistant provides services to over 500 locations throughout the United States. For more information, go to: